Comunicati Stampa
Salute e Benessere

Cambrex Opens New Stability Storage Facility in Durham, North Carolina

Tom Loewald, Cambrex CEO, stated, "After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the growth of Q1 Scientific." Tom Loewald, Cambrex CEO, stated, "After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the...
EAST RUTHERFORD, N.J., (informazione.it - comunicati stampa - salute e benessere)

Tom Loewald , Cambrex CEO, stated, "After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the growth of Q1 Scientific."

Q1 Scientific's expansion complements its existing facilities in Waterford, Ireland and Liège, Belgium , and is co-located within Cambrex's existing analytical services site in Durham. 

Stephen Delaney , Managing Director of Q1 Scientific, added, "With the capabilities and expertise co-located in Durham , we can now deliver services beyond stability storage, such as stability testing and other analytical services for clinical and commercial products."

Cambrex continues to expand its capabilities and capacity across its North American and European network to meet the growing demand for outsourced drug development and manufacturing services.

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services.

With over 40 years of experience and a team of 2,000 experts servicing global clients from North America and Europe , Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs.

Q1 Scientific, a Cambrex Company, is a leading provider of environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries. With a decade of expertise, Q1 Scientific safeguards critical breakthroughs and life-changing innovations at state-of-the-art facilities in Ireland and Belgium . By utilizing Q1 Scientific's services, companies can accelerate the introduction of new drugs to the market while avoiding the expense of building and monitoring their own storage chambers. In June 2022 , Q1 Scientific was acquired Cambrex.


 



View original content: https://www.prnewswire.co.uk/news-releases/cambrex-opens-new-stability-storage-facility-in-durham-north-carolina-302278290.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili